Study group (n=47) | Controls (n=42) | |
---|---|---|
Mean age in months (range) | 35.7 (7-116) | 37.4 (7-93) |
Male (%) | 34 (72) | 27 (64) |
Coryzal symptoms (%) | 39 (83) | 29 (69) |
Croup | ||
Mild (1-3) (%) | 16/46* (35) | 15/41* (37) |
Moderate (4-8) (%) | 23/46* (50) | 20/41* (49) |
Severe (9-17) (%) | 7/46* (15) | 6/41* (15) |
Respiratory rate/min (SD) | 33.9 (8.9) | 33.8 (8.5) |
Heart rate/min (SD) | 131 (21.3) | 129 (18.5) |
Temperature (°C) (SD) | 37.1 (0.83) | 37.2 (0.81) |
3-150 The initial croup score from one patient from each group was not entered in the analysis due to prior treatment with nebulised adrenaline.